Globus Medical Signals Post-Merger Strength with Q4 Profit Advance
Globus Medical (GMED) reported a year-over-year advance in fourth-quarter profit, underscoring the successful integration of its $3.1 billion NuVasive acquisition. The results highlight the company's growing dominance in the spine robotics and musculoskeletal markets.